✦ LIBER ✦

An automated comprehensive diagnosis and selection of treatment procedure for benign prostate hyperplasia

✍ Scribed by N. T. Berezutskii; O. B. Popova

Publisher: Springer US
Year: 1997
Tongue: English
Weight: 256 KB
Volume: 31
Category: Article
ISSN: 0006-3398
DOI: 10.1007/bf02365961

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Diagnosis and Treatment of Benign Prosta

Diagnosis and Treatment of Benign Prostatic Hyperplasia: Practice Patterns of Primary Care Physicians

✍ Mary McNaughton Collins; Michael J. Barry; Lin Bin; Richard G. Roberts; Joseph E 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

The role of urodynamics in the diagnosis

The role of urodynamics in the diagnosis and treatment of benign prostatic hyperplasia

✍ J. Quentin Clemens 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 804 KB

Workgroup #3: Monitoring effects of trea

Workgroup #3: Monitoring effects of treatment for cancer and for benign prostatic hyperplasia

✍ George W. Jones; Robert A. Smith; John D. Batjer; David G. Bostwick; Benjamin W. 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB 👁 2 views

Optimization of ultrasound array designs

Optimization of ultrasound array designs for high intensity focused treatment of prostate cancer and benign prostatic hyperplasia

✍ Khaldon Lweesy; Luay Fraiwan; Osama Al-Bataineh; Naser Hamdi; Hartmut Dickhaus 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 453 KB

Evaluating the efficacy, safety, and cos

Evaluating the efficacy, safety, and cost of lasers for the treatment of benign prostatic hyperplasia

✍ C. M. Dixon 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 465 KB

Urodynamic effects of silodosin, a new α

Urodynamic effects of silodosin, a new α1A-adrenoceptor selective antagonist, for the treatment of benign prostatic hyperplasia

✍ Tomonori Yamanishi; Tomoya Mizuno; Katsuhisa Tatsumiya; Miho Watanabe; Takao Kam 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

## Aims: To investigate urodynamically the effects of silodosin, a new alpha(1a)-adrenoceptor-selective antagonist, in the treatment of benign prostatic hyperplasia (bph). ## Methods: Thirty six male patients with bph (69.9 +/- 7.3 years), who were referred as candidates for surgery, were treated